Skip to main content
Springer Nature Link
Log in

Capecitabine/cisplatin

Neutropenia: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • McPartlin AJ, et al. Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: Experience outside of a trial setting. Chemotherapy (Basel) 59: [7 pages], No. 1, Aug 2013. Available from: URL: http://doi.org/10.1159/000348816 - United Kingdom

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Capecitabine/cisplatin. Reactions Weekly 1553, 74 (2015). https://doi.org/10.1007/s40278-015-1839-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-1839-4